Abstract
With the discovery of COX, pain has not been treated in a relentless manner. Numbers of drugs with fewer side effects were discovered and are used successfully for treatment of pain. With new research coming into being since the discovery of COX, it was established that COX can be targeted not only for treatment of pain but for curing various diseases like cancer, Alzheimer’s, Parkinson’s disease, Glaucoma etc. With the sighting of COX-3, another isoform of COX, new diseases are being targeted for better treatment.
Keywords: Anticancer, COX, COX-3, cyclooxygenase, inflammation, NSAIDs, pain.
Graphical Abstract
Inflammation & Allergy - Drug Targets (Discontinued)
Title:The Ambidextrous Cyclooxygenase: An Enduring Target
Volume: 13 Issue: 6
Author(s): Mayank Bapna and Lalit Singh Chauhan
Affiliation:
Keywords: Anticancer, COX, COX-3, cyclooxygenase, inflammation, NSAIDs, pain.
Abstract: With the discovery of COX, pain has not been treated in a relentless manner. Numbers of drugs with fewer side effects were discovered and are used successfully for treatment of pain. With new research coming into being since the discovery of COX, it was established that COX can be targeted not only for treatment of pain but for curing various diseases like cancer, Alzheimer’s, Parkinson’s disease, Glaucoma etc. With the sighting of COX-3, another isoform of COX, new diseases are being targeted for better treatment.
Export Options
About this article
Cite this article as:
Bapna Mayank and Chauhan Singh Lalit, The Ambidextrous Cyclooxygenase: An Enduring Target, Inflammation & Allergy - Drug Targets (Discontinued) 2014; 13 (6) . https://dx.doi.org/10.2174/1871528114666150401105545
DOI https://dx.doi.org/10.2174/1871528114666150401105545 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Recent Developments in Nanoparticle Based Targeted Delivery of Chemotherapeutics
Current Bioactive Compounds The Glutathione System and its Regulation by Neurohormone Melatonin in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Clinical Proteomics in Cancer Research
Current Proteomics Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where Do We Stand?
Current Pharmaceutical Design Bladder Cancer: A Simple Model Becomes Complex
Current Genomics MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Current Pharmaceutical Design New Insights on Fak and Fak Inhibitors
Current Medicinal Chemistry Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins
Anti-Cancer Agents in Medicinal Chemistry Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
Current Stem Cell Research & Therapy The Toolbox of Designing Nanoparticles for Tumors
Mini-Reviews in Medicinal Chemistry The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Current Cancer Drug Targets Molecular and Cellular Activities of Vitamin E Analogues
Mini-Reviews in Medicinal Chemistry Transition Metal Based Anticancer Drugs
Current Topics in Medicinal Chemistry Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation
Anti-Cancer Agents in Medicinal Chemistry Role of Alterations in the Apoptotic Machinery in Sensitivity of Cancer Cells to Treatment
Current Pharmaceutical Design Mast Cell Disorders In Drug Hypersensitivity
Current Pharmaceutical Design Liposomes: A Review of Manufacturing Techniques and Targeting Strategies
Current Nanoscience Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine
Current Pharmaceutical Design Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology